130 related articles for article (PubMed ID: 33027304)
1. The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies.
Noto FK; Sangodkar J; Adedeji BT; Moody S; McClain CB; Tong M; Ostertag E; Crawford J; Gao X; Hurst L; O'Connor CM; Hanson EN; Izadmehr S; Tohmé R; Narla J; LeSueur K; Bhattacharya K; Rupani A; Tayeh MK; Innis JW; Galsky MD; Evers BM; DiFeo A; Narla G; Jamling TY
PLoS One; 2020; 15(10):e0240169. PubMed ID: 33027304
[TBL] [Abstract][Full Text] [Related]
2. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
3. A novel immunodeficient rat model supports human lung cancer xenografts.
He D; Zhang J; Wu W; Yi N; He W; Lu P; Li B; Yang N; Wang D; Xue Z; Zhang P; Fan G; Zhu X
FASEB J; 2019 Jan; 33(1):140-150. PubMed ID: 29944447
[TBL] [Abstract][Full Text] [Related]
4. Sprague Dawley
Noto FK; Adjan-Steffey V; Tong M; Ravichandran K; Zhang W; Arey A; McClain CB; Ostertag E; Mazhar S; Sangodkar J; DiFeo A; Crawford J; Narla G; Jamling TY
Mol Cancer Ther; 2018 Nov; 17(11):2481-2489. PubMed ID: 30206106
[TBL] [Abstract][Full Text] [Related]
5. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance.
Kita K; Fukuda K; Takahashi H; Tanimoto A; Nishiyama A; Arai S; Takeuchi S; Yamashita K; Ohtsubo K; Otani S; Yanagimura N; Suzuki C; Ikeda H; Tamura M; Matsumoto I; Yano S
Cancer Sci; 2019 Oct; 110(10):3215-3224. PubMed ID: 31432603
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.
Guerrera F; Tabbò F; Bessone L; Maletta F; Gaudiano M; Ercole E; Annaratone L; Todaro M; Boita M; Filosso PL; Solidoro P; Delsedime L; Oliaro A; Sapino A; Ruffini E; Inghirami G
PLoS One; 2016; 11(1):e0145100. PubMed ID: 26731692
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].
Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387
[TBL] [Abstract][Full Text] [Related]
9. Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.
Fang T; Huang H; Li X; Liao J; Yang Z; Hoffman RM; Cheng XI; Liang L; Hu W; Yun S
Anticancer Res; 2018 Jan; 38(1):179-186. PubMed ID: 29277771
[TBL] [Abstract][Full Text] [Related]
10. Humanized mouse model supports development, function, and tissue residency of human natural killer cells.
Herndler-Brandstetter D; Shan L; Yao Y; Stecher C; Plajer V; Lietzenmayer M; Strowig T; de Zoete MR; Palm NW; Chen J; Blish CA; Frleta D; Gurer C; Macdonald LE; Murphy AJ; Yancopoulos GD; Montgomery RR; Flavell RA
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9626-E9634. PubMed ID: 29078283
[TBL] [Abstract][Full Text] [Related]
11. Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models.
Ménoret S; Ouisse LH; Tesson L; Delbos F; Garnier D; Remy S; Usal C; Concordet JP; Giovannangeli C; Chenouard V; Brusselle L; Merieau E; Nerrière-Daguin V; Duteille F; Bellier-Waast F; Fraichard A; Nguyen TH; Anegon I
Transplantation; 2018 Aug; 102(8):1271-1278. PubMed ID: 29688994
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a patient-derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary.
Tamauchi S; Suzuki S; Xuboya C; Yoshihara M; Yoshida K; Ikeda Y; Yoshikawa N; Kajiyama H; Kikkawa F
J Obstet Gynaecol Res; 2021 Feb; 47(2):713-719. PubMed ID: 33300248
[TBL] [Abstract][Full Text] [Related]
13. Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor.
Nanni P; Nicoletti G; Palladini A; Croci S; Murgo A; Ianzano ML; Grosso V; Stivani V; Antognoli A; Lamolinara A; Landuzzi L; di Tomaso E; Iezzi M; De Giovanni C; Lollini PL
PLoS One; 2012; 7(6):e39626. PubMed ID: 22737248
[TBL] [Abstract][Full Text] [Related]
14. Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies.
Zhou Q; Facciponte J; Jin M; Shen Q; Lin Q
Cancer Lett; 2014 Mar; 344(1):13-19. PubMed ID: 24513265
[TBL] [Abstract][Full Text] [Related]
15. The evidence of a macrophage barrier in the xenotransplantation of human hematopoietic stem cells to severely immunodeficient rats.
Furuya K; Zheng YW; Ge JY; Zhang L; Furuta T; Liang C; Abe H; Yagi H; Hamada H; Isoda H; Hui L; Ohkohchi N; Oda T
Xenotransplantation; 2021 Jul; 28(4):e12702. PubMed ID: 34145650
[TBL] [Abstract][Full Text] [Related]
16. A high-quality severe combined immunodeficiency (SCID) rat bioresource.
Miyasaka Y; Wang J; Hattori K; Yamauchi Y; Hoshi M; Yoshimi K; Ishida S; Mashimo T
PLoS One; 2022; 17(8):e0272950. PubMed ID: 35960733
[TBL] [Abstract][Full Text] [Related]
17. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.
Ilie M; Nunes M; Blot L; Hofman V; Long-Mira E; Butori C; Selva E; Merino-Trigo A; Vénissac N; Mouroux J; Vrignaud P; Hofman P
Cancer Med; 2015 Feb; 4(2):201-11. PubMed ID: 25470237
[TBL] [Abstract][Full Text] [Related]
18. Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib.
Lee AQ; Ijiri M; Rodriguez R; Gandour-Edwards R; Lee J; Tepper CG; Li Y; Beckett L; Lam K; Goodwin N; Satake N
Front Oncol; 2021; 11():648097. PubMed ID: 33842362
[TBL] [Abstract][Full Text] [Related]
19. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
